Synthetic lethality for linking the mycophenolate mofetil mode of action with molecular disease and drug profiles
Published 2012 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Synthetic lethality for linking the mycophenolate mofetil mode of action with molecular disease and drug profiles
Authors
Keywords
-
Journal
Molecular BioSystems
Volume 8, Issue 12, Pages 3197
Publisher
Royal Society of Chemistry (RSC)
Online
2012-09-06
DOI
10.1039/c2mb25256b
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Nowotwory po przeszczepie nerki
- (2015) Ewa Watorek et al. Annals of Transplantation
- Synthetic lethality of PARP inhibition in BRCA-network disrupted tumor cells is associated with interferon pathway activation and enhanced by interferon-γ
- (2012) Paul Warrener et al. APOPTOSIS
- Aurora A Inhibitor (MLN8237) plus Vincristine plus Rituximab Is Synthetic Lethal and a Potential Curative Therapy in Aggressive B-cell Non-Hodgkin Lymphoma
- (2012) D. Mahadevan et al. CLINICAL CANCER RESEARCH
- Synthetic Lethality-Based Therapeutics: Perspectives for Applications in Colorectal Cancer
- (2012) D. Soncini et al. CURRENT CANCER DRUG TARGETS
- Everolimus in Different Combinations as Maintenance Immunosuppressive Therapy in Heart Transplant Recipients
- (2012) Martin Schweiger et al. Experimental and Clinical Transplantation
- Disparities in the association of the ryanodine receptor and the FK506-binding proteins in mammalian heart
- (2012) S. Zissimopoulos et al. JOURNAL OF CELL SCIENCE
- FKBP12 Activates the Cardiac Ryanodine Receptor Ca2+-Release Channel and Is Antagonised by FKBP12.6
- (2012) Elena Galfré et al. PLoS One
- Mycophenolate Mofetil Decreases Atherosclerotic Lesion Size by Depression of Aortic T-Lymphocyte and Interleukin-17–Mediated Macrophage Accumulation
- (2011) Sibylle von Vietinghoff et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- PARP Inhibitors in BRCA Gene-Mutated Ovarian Cancer and Beyond
- (2011) Susana Banerjee et al. Current Oncology Reports
- Ensembl BioMarts: a hub for data retrieval across taxonomic space
- (2011) R. J. Kinsella et al. Database-The Journal of Biological Databases and Curation
- Trypanosoma cruzi in the Chicken Model: Chagas-Like Heart Disease in the Absence of Parasitism
- (2011) Antonio R. L. Teixeira et al. PLoS Neglected Tropical Diseases
- Mycophenolate mofetil attenuates plaque inflammation in patients with symptomatic carotid artery stenosis
- (2010) Sander I. van Leuven et al. ATHEROSCLEROSIS
- Transplantation for Chagas’ disease: an overview of immunosuppression and reactivation in the last two decades
- (2010) Fernando Bacal et al. CLINICAL TRANSPLANTATION
- Charting the genetic interaction map of a cell
- (2010) Michael Costanzo et al. CURRENT OPINION IN BIOTECHNOLOGY
- Familial neonatal isolated cardiomyopathy caused by a mutation in the flavoprotein subunit of succinate dehydrogenase
- (2010) Aviva Levitas et al. EUROPEAN JOURNAL OF HUMAN GENETICS
- SDHA is a tumor suppressor gene causing paraganglioma
- (2010) Nelly Burnichon et al. HUMAN MOLECULAR GENETICS
- Synthetic lethal hubs associated with vincristine resistant neuroblastoma
- (2010) Raul Fechete et al. Molecular BioSystems
- Skeletal Diseases in Cushing’s Syndrome: Osteoporosis versus Arthropathy
- (2010) Gregory Kaltsas et al. NEUROENDOCRINOLOGY
- Hypertension in Cushing’s Syndrome: From Pathogenesis to Treatment
- (2010) Maria Verena Cicala et al. NEUROENDOCRINOLOGY
- DrugBank 3.0: a comprehensive resource for 'Omics' research on drugs
- (2010) C. Knox et al. NUCLEIC ACIDS RESEARCH
- Mycophenolic Acid Displays IMPDH-Dependent and IMPDH-Independent Effects on Renal Fibroblast Proliferation and Function
- (2010) Darinka T Petrova et al. THERAPEUTIC DRUG MONITORING
- Efficacy and safety of rituximab in moderately-to-severely active systemic lupus erythematosus: The randomized, double-blind, phase ii/iii systemic lupus erythematosus evaluation of rituximab trial
- (2009) Joan T. Merrill et al. ARTHRITIS AND RHEUMATISM
- Comparison of two mycophenolate mofetil dosing regimens after hematopoietic cell transplantation
- (2009) P Jacobson et al. BONE MARROW TRANSPLANTATION
- Pharmacokinetic Optimization of Immunosuppressive Therapy in Thoracic Transplantation: Part I
- (2009) Caroline Monchaud et al. CLINICAL PHARMACOKINETICS
- A dependency graph approach for the analysis of differential gene expression profiles
- (2009) Andreas Bernthaler et al. Molecular BioSystems
- DRYGIN: a database of quantitative genetic interaction networks in yeast
- (2009) Judice L. Y. Koh et al. NUCLEIC ACIDS RESEARCH
- Use of mycophenolate mofetil in inflammatory bowel disease
- (2009) Terrence Tan et al. WORLD JOURNAL OF GASTROENTEROLOGY
- Phylogenetic and Functional Assessment of Orthologs Inference Projects and Methods
- (2009) Adrian M. Altenhoff et al. PLoS Computational Biology
- Systematic Mapping of Genetic Interaction Networks
- (2008) Scott J. Dixon et al. Annual Review of Genetics
- Sirolimus affects cardiomyocytes to reduce left ventricular mass in heart transplant recipients
- (2008) S. S. Kushwaha et al. EUROPEAN HEART JOURNAL
- Mycophenolate mofetil and triptolide alleviating airway inflammation in asthmatic model mice partly by inhibiting bone marrow eosinophilopoiesis
- (2008) Hui Mao et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- Acute heart inflammation: ultrastructural and functional aspects of macrophages elicited by Trypanosoma cruzi infection
- (2008) Rossana C. N. Melo JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- Calcineurin B of the human protozoan parasite Trypanosoma cruzi is involved in cell invasion
- (2008) Jorge E. Araya et al. MICROBES AND INFECTION
- eSGA: E. coli synthetic genetic array analysis
- (2008) Gareth Butland et al. NATURE METHODS
- Influence of treatment with immunosuppressive drugs in mice chronically infected with Trypanosoma cruzi
- (2003) SONIA G. ANDRADE et al. INTERNATIONAL JOURNAL OF EXPERIMENTAL PATHOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started